Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
OptiBiotix launches SlimBiome products on Amazon India
(Sharecast News) - OptiBiotix Health announced the launch of multiple SlimBiome-containing products under its GoFigure brand on Amazon India on Monday, marking a strategic expansion into the country's rapidly growing weight management market. The AIM-traded firm said the initiative was part of its broader multi-channel strategy aimed at increasing product sales through both online and in-store channels.
India, now the world's most populous nation, was projected to have the largest cohort of medium- to high-income consumers by 2035.
With obesity prevalence currently at 40.3%, the board said the market presented significant opportunities for weight management solutions.
OptiBiotix said its wholly-owned OptiBiotix India subsidiary would sell GoFigure products via Amazon, in addition to their existing presence in Apollo Pharmacies and on Apollo's e-commerce platform.
The launch on Amazon India coincided with a rebranding of the product's packaging and a relaunch in Apollo pharmacies.
OptiBiotix said the new design featured more vibrant colours to enhance visibility, and included prominent branding of Tata's Fossence, a locally-recognised ingredient aimed to enhance consumer trust and familiarity.
The GoFigure range is manufactured in India using local suppliers, incorporating Tata's proprietary Fossence prebiotic ingredient.
"Launching products on Amazon India is another step forward in building a presence for the Company's products in the strategically important Indian market," said chief executive officer Stephen O'Hara.
"We are now building SlimBiome's presence across India via our own brand products through Amazon India and via Apollo pharmacies, and as private label partnerships following the recent launch by Dr Morepen.
"This initial launch will include four products with subsequent launches taking place throughout 2025 dependent on sales progress."
At 1515 GMT, shares in OptiBiotix Health were up 5.41% at 17.92p.
Reporting by Josh White for Sharecast.com.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
